Japan is Asia’s engine for advanced drug discovery, a global leader in innovation, quality, and regulatory excellence. As the world’s third-largest pharma market, it’s home to groundbreaking R&D, high production standards, and unmatched trust in healthcare.

PSCI Members Wenjia Xu and Kozo Ohashi will be presenting on the Threat of AMR and Pharmaceutical Responsibility: Industry-Wide Initiatives and SHIONOGI Group Actions.

This presentation follows on from the successful webinar on this subject that took place in December 2025. Additional information about the PSCI and our mission and vision will also be presented.

The presentation will take place on 21 April. To register for the session, click here.

About CPHI Japan
CPHI Japan provides connections to the thriving ecosystem and access to the companies, insights, and opportunities shaping the future of pharmaceuticals across Asia Pacific.